References
- Brock S., Krieger H. P. The basis of clinical neurology, 4th ed. The Williams and Wilkins Company, Baltimore, Maryland 1963; 498
- Ferrari W. G., Gessa L., Vargiu L. Behavioral effects induced by intracisternally injected ACTH and MSH. Annals New York Academy of Science 1963; 104: 330–345
- Holmgren B., Urba-Holmgren R. Interaction of cholinergic and dopaminergic influences on yawning behavior. Acta of Neurobiological Experiments 1980; 40: 633–642
- Jackson J. Z., Jankovic J., Ford J. Progressive supranuclear palsy: Clinical features and response to treatment in 16 patients. Annals of Neurology 1983; 13: 272–278
- Mogilnicka E., Klimek V. Drugs affecting dopamine neurons and yawning behavior. Pharmacology, Biochemistry and Behavior 1977; 7: 303–305
- Rollinson R. D., Wiggins W. S., Gilligan B. S. Drug-induced yawning successfully treated with pimozide. A rchives of Neurology 1979; 36: 253
- Steele J. C., Richardson J. C., Olszewski J. Progressive supranuclear palsy. Archives of Neurology 1964; 10: 333–359
- Urba-Holmgren R., Holmgren B. Is yawning a cholinergic response?. Nature 1977; 267: 261–262
- Yamada K., Furukawa T. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology 1980; 67: 39–43
- Yamada K., Furukawa T. The yawning elicited by alpha-melanocyte stimulating hormone involves serotoninergic dopaminergic-cholinergic neuron link in rats. Archives of Pharmacology 1981; 316: 155–160